Mylan (MYL), Endo (ENDP) Gain on Valeant Headlines

November 1, 2016 3:48 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Endo Int'l (NASDAQ: ENDP), Mylan (NASDAQ: MYL) gain on reports Valeant Pharma (NYSE: VRX) is in advanced talks to sell Salix to Takeda for $10 billion.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Trader Talk

Add Your Comment